Viking Therapeutics, Inc. company mark

Viking Therapeutics, Inc. Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: VKTX
Sector: Healthcare
Industry: Biotechnology
Market Cap $4.41B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

Viking Therapeutics, Inc. Business Intelligence Hub

The Viking Therapeutics, Inc. Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on Viking Therapeutics, Inc.. This page always opens the latest Business Intelligence annual report and stays in sync with Viking Therapeutics, Inc.'s newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

Viking Therapeutics, Inc. Financial Performance & Statements

Explore Viking Therapeutics, Inc.'s financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

Viking Therapeutics, Inc. Quarterly Earnings & Management Commentary

Read the latest Viking Therapeutics, Inc. quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

Viking Therapeutics, Inc. Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

Viking Therapeutics, Inc. Sector, Valuation & Risk Analysis

See Viking Therapeutics, Inc. in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: Viking Therapeutics, Inc. annual report, Viking Therapeutics, Inc. AI annual report, Viking Therapeutics, Inc. fundamental analysis, Viking Therapeutics, Inc. business analysis, Viking Therapeutics, Inc. financial performance, Viking Therapeutics, Inc. financial statements, Viking Therapeutics, Inc. growth analysis, Viking Therapeutics, Inc. management analysis, Viking Therapeutics, Inc. corporate governance, Viking Therapeutics, Inc. cash flow analysis, Viking Therapeutics, Inc. business intelligence, Viking Therapeutics, Inc. valuation, Viking Therapeutics, Inc. quarterly results, Viking Therapeutics, Inc. earnings summary, Viking Therapeutics, Inc. management commentary, Viking Therapeutics, Inc. sector analysis, Viking Therapeutics, Inc. company research, Viking Therapeutics, Inc. equity research, Viking Therapeutics, Inc. stock analysis, Viking Therapeutics, Inc. AI company analysis, Viking Therapeutics, Inc. capital allocation, Viking Therapeutics, Inc. risk analysis, Viking Therapeutics, Inc. competitive position, Viking Therapeutics, Inc. long-term growth.